Table 1 Antibiotic susceptibility profile of S. Typhi isolates in Jakarta
Antibiotic | Sensitive (n = 28) | Intermediate (n = 28) | Resistant (n = 28) |
|---|---|---|---|
Ciprofloxacin (CLSI 2020) | 27 (96.4%) | 1 (3.6%) | 0 |
Levofloxacin (EUCAST 2022) | 28 (100%) | 0 | 0 |
Nalidixic acid (CLSI 2011) | 28 (100%) | 0 | 0 |
Moxifloxacin (EUCAST 2022) | 28 (100%) | 0 | 0 |